Lung cancer

Last updated: 01 November 2019

You can legally access new medicines, even if they are not approved in your country.

Learn more »

A phase 3 study on lung cancer showed that Imfinzi (durvalumab) as a consolidation therapy reduced the risk of the disease progressing by 48 percent.

Read more